Eupraxia Pharmaceuticals is trading 18.05% up at $7.98 in after-hours trading, with no verified company announcement explaining the move.
- Shares closed at $6.76 on November 2.
- Q3 2026 results are expected before the market opens November 3, but the date is an estimate, not a confirmed release catalyst.
- Available market context is mixed and does not clearly account for the sharp gain.